Jing Ma
Guangzhou Medical University
8 Papers
5 Citations
Jing Ma is an academic researcher from Guangzhou Medical University. The author has contributed to research in topics: Medicine & Antibody. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
Clinical application of fractional exhaled nitric oxide and nasal nitric oxide levels for the assess eosinophilic inflammation of allergic rhinitis among children.
Jia-Ying Luo,Hui-An Chen,Jing Ma,Yong-Xin Xiao,Jing-Jiong Yao,Jia-Min Liang,Ying-Si Du,Feng Wang,Baoqing Sun +8 more
TL;DR: Using NO concentration can indicates the extent of allergic inflammation and can measure allergy treatment effects combine other influence indexes, and the combined use of FeNO and nNO levels may be a useful method for assess the degree of eosinophilic inflammation of allergic rhinitis in children.
Clinical Efficacy of Sanfeng Tongqiao Diwan in the Treatment of Allergic Rhinitis: A Randomized Controlled Trial
TL;DR: Sanfeng Tongqiao Diwan can significantly alleviate the symptoms and improve the quality of life of patients with allergic rhinitis, with less adverse reactions.
Broad and durable antibody response after vaccination with inactivated SARS-CoV-2 in individuals with a history of 2003 SARS-CoV infection
Huan Liang,Peiyan Zheng,Qian Wang,Yijun Deng,D. Liang,Haisu Yi,Yuanyi Cheng,Xinwei Zhao,Jing Ma,Yidong Yang,Peiyu Hu,Pingqian Zheng,Yudi Zhang,Shuangshuang Huang,Xia Lin,Changwen Ke,Xuefeng Niu,Baoqing Sun,Lingdan Chen +18 more
TL;DR: Findings suggested a great possibility of developing a universal vaccine by heterologous vaccination using spike antigens from different SARS-related coronaviruses as well as neutralizing activities measured by authentic viruses and pseudoviruses.
2
Umbilical cord blood metabolomics: association with intrauterine hyperglycemia.
TL;DR: In this article, the authors explored differences in metabolites and metabolic pathways between individuals with hyperglycemia or well-controlled gestational diabetes mellitus (GDM) and healthy controls.
2
Evaluating SARS-CoV-2 antibody reactivity to natural exposure and inactivated vaccination with peptide microarrays
Peiyan Zheng,Jing Ma,Jiao Yang,Baolin Liao,Zhangkai J Cheng,Mingshan Xue,Shiyun Li,Yanting Fang,Runpei Lin,Guizhen Zhang,Huimin Huang,Fengyu Hu,Hongwei Ma,Bao-hua Sun +13 more
TL;DR: In this paper , the authors used SARS-CoV-2 peptide microarrays to assess the differences between 44 volunteers inoculated with the inactivated virus vaccine BBIBP-CorV and 61 patients who were infected with SARS CoV-II, and found that the specific antibody responses against S15, S64, and S104 peptides were stronger in vaccinators than in infected persons.